Last reviewed · How we verify
NCT03746574
Achieving the Quadruple Aim by Reducing Burnout
NA trial testing Compassion Curriculum in Burnout, Professional in 341 participants. Completed in 31 December 2016.
1 July 2016
Quick facts
| Lead sponsor | Providence Health & Services |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 341 |
| Start date | 1 January 2016 |
| Primary completion | 1 July 2016 |
| Estimated completion | 31 December 2016 |
Drugs / interventions tested
- Compassion Curriculum
Conditions studied
- Burnout, Professional — all drugs for Burnout, Professional →
Sponsor
Providence Health & Services — full company profile →
Who can join
Eligibility, any sex, with Burnout, Professional. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To demonstrate that a multimodal intervention can reduce burnout in a multidisciplinary primary care practice while improving other components of the Quadruple Aim including staff engagement, patient experience, productivity and quality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03746574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burnout, Professional
Currently open trials in the same condition.
- NCT07221422 — The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project · NA · recruiting
- NCT07423468 — Developing Competency Awareness and Clinical Coordination in a Neonatal Unit · NA · active not recruiting
- NCT07262372 — Supervision in Substance Use Disorder Treatment Programs · NA · recruiting
- NCT07089160 — Decision Fatigue and Emotional Exhaustion Among Anesthesiologists · recruiting
- NCT05942469 — Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) · NA · recruiting
Other Providence Health & Services trials
Trials by the same sponsor.
- NCT06175000 — Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Parti · Phase 2 · recruiting
- NCT04987996 — GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients · Phase 2 · withdrawn
- NCT05349890 — Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) · Phase 1 · active not recruiting
- NCT04796584 — Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication · terminated
- NCT04417699 — SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03746574 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Providence Health & Services
- Last refreshed: 19 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03746574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing